Temporomandibular DysfunctionNCT06772012
Effectiveness of Low-Level Laser Therapy (LLLT) Versus Orofacial Physical Therapy for Temporomandibular Dysfunction. A Randomized Controlled Trial
A study testing Low-Level Laser Therapy (LLLT) and Orofacial Physical Therapy in people with Temporomandibular Dysfunction, run by Bahria University at 1 site in Pakistan.
Trial summary
This study will investigate if Low-Level Laser Therapy (LLLT) is more effective than Orofacial Physical Therapy for treating Temporomandibular Dysfunction. By conducting a randomized controlled trial, it aims to fill gaps in current knowledge, improve TMD treatment options, and enhance patient outcomes. Read more about this study
- Who is it for?
- Ages 30 years and olderHealthy volunteers can take part
- Conditions the study is for
- Temporomandibular Dysfunction
- What is being tested?
- Low-Level Laser Therapy (LLLT) and Orofacial Physical Therapy
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 20 participants
- Where
- 1 sitePakistan
- Study dates
- 1 Sep 2023to 2 Dec 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 30 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- 1) limited mouth opening or function(49) 2) presence of pain in masticatory muscles and/or TMJs(49) 3) muscular disturbance (49) 4) arthralgia(49)
Who cannot join
- 1) major systemic disorders (49) 2) who received analgesic or anti-depressants over the last 2 weeks(49) 3) had any bony abnormalities of the jaws (49) 4) psychological illness (49) 5) pregnant and feeding women (49)
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Effectiveness of Low-Level Laser Therapy (LLLT) Versus Orofacial Physical Therapy for Temporomandibular Dysfunction. A Randomized Controlled Trial.
This study will investigate if Low-Level Laser Therapy (LLLT) is more effective than Orofacial Physical Therapy for treating Temporomandibular Dysfunction. By conducting a randomized controlled trial, it aims to fill gaps in current knowledge, improve TMD treatment options, and enhance patient outcomes.
Read the detailed description
In the last 30 years, many nonsurgical therapies have been suggested for the treatment of temporomandibular disorders (TMD), including physical therapy, pharmacologic therapy, occlusal splints, occlusal adjustment, acupuncture, and low-level laser therapy (LLLT). (1) The main objective of all these treatment modalities is to reduce symptom intensity, thereby improving the function of the masticatory system and adjacent structures.(2) Signs and symptoms of TMD are present in 86% of the population, being more frequent among women, also related to dental occlusion and emotional stress. Are considered signs: limited mouth opening, joint sounds and deviation of the mandible to one side during opening and closing, muscle spasm, pain reflex, impaired joint motion, crepitus, headache and hearing disorders. Otologic symptoms are represented by decreased hearing, vertigo and tinnitus, which can be related to the ontogenetic and anatomical relationship between the middle ear and masticatory structures.(3) Among nonsurgical treatments, LLLT has increased in interest in the last few years, probably due to its ease of use in combination with reports of positive effects on pain alleviation. (4) LLLT is a non-thermal type of light, which causes internal changes in cells and tissues, leading to different types of metabolic activations. (5) These include stimulation of the cellular respiratory chain and increase in vascularization and fibroblast formation which have been suggested to play an important role in the analgesic effect of LLLT. Despite the fact that there is no universally accepted theory to explain the mechanism of either "laser analgesia" or "laser bio stimulation,"(6) LLLT can be expected to promote some anti-inflammatory effect and pain relief in painful and dysfunctional joints and muscles.(7) The most clinically used LLLT include the helium-neon laser (632 nm He-Ne) and infrared laser, as diode-gallium-arsenide (904 nm Ga-As) or gallium-aluminium-arsenide (830 nm Ga-Al-As). The mechanism of pain relief via mid-laser therapy is not clearly understood and several theories have been suggested. One theory considers the analgesic effect to be a consequence of the reduction of levels of prostaglandin E2 (PGE2 ), which is one of the most important proinflammatory mediators. This theory is based on in vivo and in vitro findings of a reduction of PGE2 both in cultures of ligament cells and in the joint capsule of animals after laser exposure. The PGE2 reduction probably derives from the inhibition made by laser radiation of cyclooxygenase-2 (COX-2), the enzyme involved in the synthesis of PGE.(8, 9) Another theory takes into account the effect of laser therapy on neuronal cells: The effect involves the possible selective inhibition of nociceptive signals16 and the microcirculation regulation; this action could interrupt the origin and development of pain and thus could provide analgesic effects.17,18 The magnitude of the laser effect seems to depend on the wavelength and dosage of the laser light.11 It has been reported that reduction of PGE2 could be observed within a range of dose between 0.4 and 19 J and within a range of power density between 5 and 21.2 mW/cm2 . (10)
Temporomandibular disorders (TMDs) are probably the most common cause of pain of non-dental origin in the maxillofacial area. The category of TMDs embraces a number of clinical problems related to masticator muscles, temporomandibular joint (TMJ) and associated structures, or both. (11) Such disorders are characterised by pain, joint sounds, and restricted mandibular movement. The incidence of TMD ranges from 40 to 75 % in general populations and approximately 65 % of affected patients experience associated pain. This great number of patients is treated using different modalities, depending on the aetiology of signs and symptoms. Conservative, rather than aggressive and irreversible, treatment is preferred to relieve symptoms, diminish pain, and re-establish function. (12, 13) As the aetiology of TMD is multifactorial, available treatments are extensive and diverse, including the use of occlusal splints, low-level laser therapy (LLLT), and transcutaneous electrical nerve stimulation, among many others. Given that better therapeutic results (i.e. pain relief ) are obtained with the combined use of modalities, several recent studies have examined the use of LLLT to reduce TMD pain and promote bio augmentation effects. (14) The LLT has demonstrated an ability to assist in the symptomatic treatment of pain, providing a considerable degree of comfort to the patient after application. The great advantage of laser applications in the treatment of TMD is that it is a non-invasive therapy, with low cost, and currently has being widely used in dental practice, reducing the demand related to the surgery or the use of drugs to treat relief pain and tissue regeneration.(15) The application of laser therapy in TMD patients has demonstrated an ability to relieve pain in few minutes after application, promoting well-being significant. However, LLT is an adjuvant treatment in pain relief by its analgesic action, which allows the patient's return to daily chores, providing comfort and better quality of life.(16) The G1 group was randomly divided into 7 therapeutic groups in which the therapy was carried out for 10 days: magneto stimulation (T1), magnetoledotherapy (T2), magnetolaserotherapy (T3), manual therapy- positional release and therapeutic exercises (T4), manual therapy - massage and therapeutic exercises (T5), manual therapy - PIR and therapeutic exercises (T6), self therapy - therapeutic exercises (T7).G2 was given LLLT. (17) Most people can open their mouth 35 to 55 millimeters (1.4 to 2.2 inches), which is about the width of 3 fingers (see Figure 2). Figure 2. Normal width of an open mouth Your jaw is made up of a pair of bones that form the framework of your mouth and teeth.(18)
This study will investigate if Low-Level Laser Therapy (LLLT) is more effective than Orofacial Physical Therapy for treating Temporomandibular Dysfunction. By conducting a randomized controlled trial, it aims to fill gaps in current knowledge, improve TMD treatment options, and enhance patient outcomes.
- Conditions
- Temporomandibular Dysfunction
- Being tested
- Low-Level Laser Therapy (LLLT), Orofacial Physical Therapy
- Keywords
- temporomandibular dysfunction
- Medical subject headings
- Temporomandibular Joint Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Low-Level Laser Therapy (LLLT)Other
- Frequency: LLLT was administered 3 times per week.
- Duration: Each session lasted approximately 15-20 minutes.
- Total Duration: The therapy was provided for a total of 6 weeks.(50)
Orofacial Physical TherapyOther
- Frequency: Orofacial physical therapy sessions were conducted 3 times per week.
- Duration: Each session lasted around 30-40 minutes.
- Total Duration: The therapy was provided for a total of 6 weeks.
- Components:
- Manual Therapy: Included techniques such as joint mobilization, soft tissue manipulation, and muscle stretching.
- Therapeutic Exercises: Focused on strengthening, coordination, and improving mobility of the masticatory muscles.
- Postural Training: Addressed poor posture and cervical muscle spasm.(50)
| Study group | Role | What they receive |
|---|---|---|
| Low-Level Laser Therapy (LLLT) | Experimental | Intervention Protocol:
* Frequency: LLLT was administered 3 times per week.
* Duration: Each session lasted approximately 15-20 minutes.
* Total Duration: The therapy was provided for a total of 6 weeks.(50) Receives: Other: Low-Level Laser Therapy (LLLT) |
| Orofacial Physical Therapy | Active comparator | Intervention Protocol:
* Frequency: Orofacial physical therapy sessions were conducted 3 times per week.
* Duration: Each session lasted around 30-40 minutes.
* Total Duration: The therapy was provided for a total of 6 weeks.
* Components:
* Manual Therapy: Included techniques such as joint mobilization, soft tissue manipulation, and muscle stretching.
* Therapeutic Exercises: Focused on strengthening, coordination, and improving mobility of the masticatory muscles.
* Postural Training: Addressed poor posture and cervical muscle spasm.(50) Receives: Other: Orofacial Physical Therapy |
What is being measured
The primary outcome is the main question the study is designed to answer.
jaw range of motion
Measured: 6 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Jan 2025
- Study start1 Sep 2023
- Primary completion30 Sep 2024
- Study completion2 Dec 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Temporomandibular DysfunctionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 20 participants (actual)
Sponsor and investigators
- Lead sponsor
- Bahria University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Seyyada Tahniat Ali, Bahria University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06772012
- Sponsor's protocol ID
- SU92-MSRSW-F22-085
- Status last verified
- Jan 2025
- First submitted
- 8 Jan 2025
- Last updated
- 13 Jan 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Petrucci A, Sgolastra F, Gatto R, Mattei A, Monaco A. Effectiveness of low-level laser therapy in temporomandibular disorders: a systematic review and meta-analysis. J Orofac Pain. 2011 Fall;25(4):298-307.
PubMed 22247925
Study at a glance
From the registry record, last updated by the sponsor on 13 Jan 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effectiveness of Low-Level Laser Therapy (LLLT) Versus Orofacial Physical Therapy for Temporomandibular Dysfunction. A Randomized Controlled Trial.
- ClinicalTrials.gov ID
- NCT06772012
- Acronym / sponsor ID
- SU92-MSRSW-F22-085
- Conditions
- Temporomandibular Dysfunction
- Keywords
- temporomandibular dysfunction
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 20 participants (actual)
- Lead sponsor
- Bahria UniversityUniversity, hospital or other
- Study start
- 1 Sep 2023 (actual)
- Primary completion
- 30 Sep 2024 (actual)
- Study completion
- 2 Dec 2024 (actual)
- First posted
- 13 Jan 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study will investigate if Low-Level Laser Therapy (LLLT) is more effective than Orofacial Physical Therapy for treating Temporomandibular Dysfunction. By conducting a randomized controlled trial, it aims to fill gaps in current knowledge, improve TMD treatment options, and enhance patient outcomes.
Detailed description
In the last 30 years, many nonsurgical therapies have been suggested for the treatment of temporomandibular disorders (TMD), including physical therapy, pharmacologic therapy, occlusal splints, occlusal adjustment, acupuncture, and low-level laser therapy (LLLT). (1) The main objective of all these treatment modalities is to reduce symptom intensity, thereby improving the function of the masticatory system and adjacent structures.(2) Signs and symptoms of TMD are present in 86% of the population, being more frequent among women, also related to dental occlusion and emotional stress. Are considered signs: limited mouth opening, joint sounds and deviation of the mandible to one side during opening and closing, muscle spasm, pain reflex, impaired joint motion, crepitus, headache and hearing disorders. Otologic symptoms are represented by decreased hearing, vertigo and tinnitus, which can be related to the ontogenetic and anatomical relationship between the middle ear and masticatory structures.(3) Among nonsurgical treatments, LLLT has increased in interest in the last few years, probably due to its ease of use in combination with reports of positive effects on pain alleviation. (4) LLLT is a non-thermal type of light, which causes internal changes in cells and tissues, leading to different types of metabolic activations. (5) These include stimulation of the cellular respiratory chain and increase in vascularization and fibroblast formation which have been suggested to play an important role in the analgesic effect of LLLT. Despite the fact that there is no universally accepted theory to explain the mechanism of either "laser analgesia" or "laser bio stimulation,"(6) LLLT can be expected to promote some anti-inflammatory effect and pain relief in painful and dysfunctional joints and muscles.(7) The most clinically used LLLT include the helium-neon laser (632 nm He-Ne) and infrared laser, as diode-gallium-arsenide (904 nm Ga-As) or gallium-aluminium-arsenide (830 nm Ga-Al-As). The mechanism of pain relief via mid-laser therapy is not clearly understood and several theories have been suggested. One theory considers the analgesic effect to be a consequence of the reduction of levels of prostaglandin E2 (PGE2 ), which is one of the most important proinflammatory mediators. This theory is based on in vivo and in vitro findings of a reduction of PGE2 both in cultures of ligament cells and in the joint capsule of animals after laser exposure. The PGE2 reduction probably derives from the inhibition made by laser radiation of cyclooxygenase-2 (COX-2), the enzyme involved in the synthesis of PGE.(8, 9) Another theory takes into account the effect of laser therapy on neuronal cells: The effect involves the possible selective inhibition of nociceptive signals16 and the microcirculation regulation; this action could interrupt the origin and development of pain and thus could provide analgesic effects.17,18 The magnitude of the laser effect seems to depend on the wavelength and dosage of the laser light.11 It has been reported that reduction of PGE2 could be observed within a range of dose between 0.4 and 19 J and within a range of power density between 5 and 21.2 mW/cm2 . (10)
Temporomandibular disorders (TMDs) are probably the most common cause of pain of non-dental origin in the maxillofacial area. The category of TMDs embraces a number of clinical problems related to masticator muscles, temporomandibular joint (TMJ) and associated structures, or both. (11) Such disorders are characterised by pain, joint sounds, and restricted mandibular movement. The incidence of TMD ranges from 40 to 75 % in general populations and approximately 65 % of affected patients experience associated pain. This great number of patients is treated using different modalities, depending on the aetiology of signs and symptoms. Conservative, rather than aggressive and irreversible, treatment is preferred to relieve symptoms, diminish pain, and re-establish function. (12, 13) As the aetiology of TMD is multifactorial, available treatments are extensive and diverse, including the use of occlusal splints, low-level laser therapy (LLLT), and transcutaneous electrical nerve stimulation, among many others. Given that better therapeutic results (i.e. pain relief ) are obtained with the combined use of modalities, several recent studies have examined the use of LLLT to reduce TMD pain and promote bio augmentation effects. (14) The LLT has demonstrated an ability to assist in the symptomatic treatment of pain, providing a considerable degree of comfort to the patient after application. The great advantage of laser applications in the treatment of TMD is that it is a non-invasive therapy, with low cost, and currently has being widely used in dental practice, reducing the demand related to the surgery or the use of drugs to treat relief pain and tissue regeneration.(15) The application of laser therapy in TMD patients has demonstrated an ability to relieve pain in few minutes after application, promoting well-being significant. However, LLT is an adjuvant treatment in pain relief by its analgesic action, which allows the patient's return to daily chores, providing comfort and better quality of life.(16) The G1 group was randomly divided into 7 therapeutic groups in which the therapy was carried out for 10 days: magneto stimulation (T1), magnetoledotherapy (T2), magnetolaserotherapy (T3), manual therapy- positional release and therapeutic exercises (T4), manual therapy - massage and therapeutic exercises (T5), manual therapy - PIR and therapeutic exercises (T6), self therapy - therapeutic exercises (T7).G2 was given LLLT. (17) Most people can open their mouth 35 to 55 millimeters (1.4 to 2.2 inches), which is about the width of 3 fingers (see Figure 2). Figure 2. Normal width of an open mouth Your jaw is made up of a pair of bones that form the framework of your mouth and teeth.(18)
This study will investigate if Low-Level Laser Therapy (LLLT) is more effective than Orofacial Physical Therapy for treating Temporomandibular Dysfunction. By conducting a randomized controlled trial, it aims to fill gaps in current knowledge, improve TMD treatment options, and enhance patient outcomes.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Low-Level Laser Therapy (LLLT) | Experimental | Other: Low-Level Laser Therapy (LLLT)Intervention Protocol: * Frequency: LLLT was administered 3 times per week. * Duration: Each session lasted approximately 15-20 minutes. * Total Duration: The therapy was provided for a total of 6 weeks.(50) |
| Orofacial Physical Therapy | Active comparator | Other: Orofacial Physical TherapyIntervention Protocol: * Frequency: Orofacial physical therapy sessions were conducted 3 times per week. * Duration: Each session lasted around 30-40 minutes. * Total Duration: The therapy was provided for a total of 6 weeks. * Components: * Manual Therapy: Included techniques such as joint mobilization, soft tissue manipulation, and muscle stretching. * Therapeutic Exercises: Focused on strengthening, coordination, and improving mobility of the masticatory muscles. * Postural Training: Addressed poor posture and cervical muscle spasm.(50) |
Who may qualify
- Ages
- 30 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- 1) limited mouth opening or function(49) 2) presence of pain in masticatory muscles and/or TMJs(49) 3) muscular disturbance (49) 4) arthralgia(49)
Key exclusion criteria (1 listed)
- 1) major systemic disorders (49) 2) who received analgesic or anti-depressants over the last 2 weeks(49) 3) had any bony abnormalities of the jaws (49) 4) psychological illness (49) 5) pregnant and feeding women (49)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Low-Level Laser Therapy (LLLT)* Frequency: LLLT was administered 3 times per week. * Duration: Each session lasted approximately 15-20 minutes. * Total Duration: The therapy was provided for a total of 6 weeks.(50) | Other | Low-Level Laser Therapy (LLLT) |
| Orofacial Physical Therapy* Frequency: Orofacial physical therapy sessions were conducted 3 times per week. * Duration: Each session lasted around 30-40 minutes. * Total Duration: The therapy was provided for a total of 6 weeks. * Components: * Manual Therapy: Included techniques such as joint mobilization, soft tissue manipulation, and muscle stretching. * Therapeutic Exercises: Focused on strengthening, coordination, and improving mobility of the masticatory muscles. * Postural Training: Addressed poor posture and cervical muscle spasm.(50) | Other | Orofacial Physical Therapy |
Primary outcome
jaw range of motion
Time frame: 6 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Jan 2025.
- Results publication: PubMed 22247925Petrucci A, Sgolastra F, Gatto R, Mattei A, Monaco A. Effectiveness of low-level laser therapy in temporomandibular disorders: a systematic review and meta-analysis. J Orofac Pain. 2011 Fall;25(4):298-307.
- Individual participant dataSharing planned: No
Related trials for Temporomandibular Dysfunction
Recruiting
Photobiomodulation for Management of Temporomandibular Disorder Pain
Pain Related to TMD
Recruiting
Effects of Vagus Nerve Stimulation on Temporomandibular Disorders.
TMD, Temporomandibular Disorders (TMDs)
Recruiting
Marine Lipids Ease Painful TMD
Temporomandibular Disorder (TMD)
Not yet recruiting
Comparing Dextrose Prolotherapy vs. Sodium Hyaluronic Acid Injections for Jaw Joint Internal Derangement
Temporomandibular Joint Internal Derangement, TMJ-ID
Recruiting
R01_Pilot Jaw Muscle Phenotypes
Chronic TMD Pain, Temporomandibular Disorder
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Low-Level Laser Therapy (LLLT) and Orofacial Physical Therapy in people with Temporomandibular Dysfunction, run by Bahria University at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 13 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
jaw range of motion (time frame: 6 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06772012, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jan 2025.